Portal de investigación
GETH-CLL4: Long-term follow-up of a pilot trial evaluating the addition of ofatumumab to the conditioning regimen of patients with chronic lymphocytic leukemia undergoing allogeneic HCT
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Lopez-Corral, Lucia
- Valcarcel, David
- Rovira, Montserrat
- Antonio Garcia-Marco, Jose
- Loscertales, Javier
- Moreno, Carol
- Duarte, Rafael
- Jose Terol, Maria
- Abrisqueta, Pau
- Cabrero, Monica
- Delgado, Julio
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Cita
Montesinos,P,Lopez,L,Valcarcel,D,Rovira,M,Antonio Garcia,J,Loscertales,J,Moreno,C et al. GETH-CLL4: Long-term follow-up of a pilot trial evaluating the addition of ofatumumab to the conditioning regimen of patients with chronic lymphocytic leukemia undergoing allogeneic HCT. 44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT). 2018. Lisbon. CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND:SPRINGERNATURE. 2018 p.p. 244-245.